Management of severe and refractory Mooren's ulcers with rituximab.

Damien GuindoletClotilde ReynaudGaelle ClavelGeorges BelangéMaycene BenmahmedSerge DoanGilles HayemIsabelle CochereauEric E Gabison

Published in: The British journal of ophthalmology (2016)

Rituximab was effective in the management of severe Mooren's ulcers and could be an alternative to cyclophosphamide. Additional studies should assess the role of this biotherapy in the management of immunological corneal ulcer.

Keyphrases

diffuse large b cell lymphoma
early onset
low dose
wound healing
high dose
drug induced
chronic lymphocytic leukemia